Courtney Havens

Courtney Havens is an accomplished professional with significant experience in the field of biology and drug discovery. Currently serving as the Director of Biology at Proteovant Therapeutics since May 2022, Courtney previously held the position of Director of Drug Discovery Biology at Treeline Biosciences from May 2021 to April 2022. A notable tenure at Pfizer spanned from April 2018 to May 2021, where roles included Senior Principal Scientist and Principal Scientist, focusing on oncology and cancer systems therapeutics. Earlier career accomplishments feature positions at Celgene, Harvard Medical School, the Howard Hughes Medical Institute at UC San Diego, and the Walter Reed Army Institute of Research, encompassing a range of scientific explorations from drug development to molecular biology research. Academic credentials include a Ph.D. in Biomedical Sciences from UC San Diego School of Medicine and a BS in Cell Molecular Biology & Genetics from the University of Maryland.